Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL16337585 | 0.99 | GAA (0.37) | GAAKDM4EALDH1A1GLACA12 | |
| SCHEMBL1923453 | 0.96 | CA12 (0.38) | GAAKDM4EALDH1A1GLACA12 | |
| Hydrochloric Acid SCHEMBL7062212 | 0.95 | CA12 (0.37) | GAAKDM4EALDH1A1GLACA12 | |
| SCHEMBL11036757 | 0.78 | KDM4E (0.33) | GAAKDM4EALDH1A1GLASIRT3 | |
| SCHEMBL8130177 | 0.78 | GAA (0.36) | GAAMAPK8MAPK9MAPK10MEN1 | |
| Acetone SCHEMBL538075 | 0.76 | CNR2 (0.41) | KDM4EALDH1A1TDP1MGLLMAPT | |
| SCHEMBL15231891 | 0.74 | RBP4 (0.43) | GAAALDH1A1MGLLMAPTCYP11B2 | |
| SCHEMBL15066588 | 0.73 | KDM4E (0.42) | GAAKDM4EALDH1A1CA12CA1 | |
| Acetone SCHEMBL1019109 | 0.73 | MAPK1 (0.40) | GAAKDM4EMAPK1MGLLL3MBTL1 | |
| Acetone SCHEMBL5667714 | 0.73 | SIRT3 (0.58) | GAAKDM4EALDH1A1GLACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10953073-B2 | XTEN conjugate compositions and methods of making same | AMUNIX PHARMACEUTICALS, INC. (US) | 2021-03-23 | — | — | US | claimed |
| EP-2494075-B1 | TEMPLATED NANOCONJUGATES | UNIV NORTHWESTERN (US) | 2018-04-04 | — | — | EP | claimed |
| US-20130052204-A1 | (POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 2013-02-28 | — | — | US | claimed |
| EP-2501403-A2 | (POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (US) | 2012-09-26 | — | — | EP | claimed |
| CN-102666879-A | Templated nanoconjugates | UNIV NORTHWESTERN | 2012-09-12 | — | — | CN | claimed |
| EP-2494075-A2 | TEMPLATED NANOCONJUGATES | Northwestern University (US) | 2012-09-05 | — | — | EP | claimed |
| EP-2341916-A1 | COLOSTRUM COMPOSITION | Nanoko A/S (DK) | 2011-07-13 | — | — | EP | claimed |
| WO-2011060379-A2 | (POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE | SNAPPER CLIFFORD M (US) | 2011-05-19 | — | — | WO | claimed |
| WO-2011053940-A2 | TEMPLATED NANOCONJUGATES | NORTHWESTERN UNIVERSITY (US) | 2011-05-05 | — | — | WO | claimed |
| EP-2249661-A2 | PRODUCTS AND METHODS TO PREVENT INFECTION | Multimerics APS (DK) | 2010-11-17 | — | — | EP | claimed |
| WO-2010028652-A1 | COLOSTRUM COMPOSITION | NANOKO A/S (DK) | 2010-03-18 | — | — | WO | claimed |
| WO-2010021639-A1 | ATTOMOLAR PROTEIN DETECTION IN COMPLEX DAMLE MATRICES WITH SEMI-HOMOGENEOUS FLUIDIC FORCE DISCRIMINATION ASSAYS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2010-02-25 | — | — | WO | claimed |
| WO-2009092383-A2 | PRODUCTS AND METHODS TO PREVENT INFECTION | MULTIMERICS APS (DK) | 2009-07-30 | — | — | WO | claimed |
| EP-4397755-A2 | DELIVERY OF THERAPEUTIC AGENTS BY A COLLAGEN BINDING PROTEIN | The Board of Trustees of the University of Arkansas (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2022117731-A9 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | Westfälische Wilhelms-Universität Münster (DE) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024092126-A1 | COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPIES | CARGO THERAPEUTICS, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20030013857-A1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INCORPORATED | 2003-01-16 | — | — | US | disclosed |
| US-20020146504-A1 | Ternary biomolecule/polymer/surface-based immobilization systems | AUDAX PRIVATE DEBT LLC, AS AGENT | 2002-10-10 | — | — | US | disclosed |
| WO-2002057422-A2 | TERNARY BIOMOLECULE/POLYMER/SURFACE-BASED IMMOBILIZATION SYSTEMS | SCHWARTZ DAVID A (US) | 2002-07-25 | — | — | WO | disclosed |
| WO-2001070685-A2 | HYDRAZINE-BASED AND CARBONYL-BASED BIFUNCTIONAL CROSSLINKING REAGENTS | SOLULINK, INCORPORATED (US) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020146504-A1 | Ternary biomolecule/polymer/surface-based immobilization systems | EPCAM, DNPEP, ANPEP | GAA 669/4885KDM4E 2841/4885ALDH1A1 552/4885 |
| US-10953073-B2 | XTEN conjugate compositions and methods of making same | XPA, TXLNA, NGLY1 | GAA 663/4885KDM4E 2338/4885ALDH1A1 3685/4885 |
| US-20030013857-A1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | HLCS, DUOX1, HAO2 | GAA 1579/4885KDM4E 1647/4885ALDH1A1 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.